Serum alkaline phosphatase and phosphate in cerebral atherosclerosis and functional outcomes after cerebral infarction

Stroke. 2013 Dec;44(12):3547-9. doi: 10.1161/STROKEAHA.113.002959. Epub 2013 Sep 10.

Abstract

Background and purpose: Higher serum alkaline phosphatase (ALP) and phosphate levels are associated with atherosclerotic disease and an increased risk of cardiovascular events. However, the association of ALP/phosphate with cerebral atherosclerosis and prognosis in patients with acute stroke is not well known.

Methods: In 1034 patients with first-ever acute cerebral infarction, levels of ALP and phosphate were compared with (1) cerebral atherosclerosis and (2) poor long-term functional outcomes as defined by the modified Rankin Scale>2 at 3 months after stroke onset.

Results: ALP levels were not associated with cerebral atherosclerosis. However, higher levels of ALP were associated with a poor functional outcome (adjusted odds ratio per 1 SD, 1.25; 95% confidence interval, 1.04-1.50). Phosphate was associated with neither cerebral atherosclerosis nor functional outcome.

Conclusions: A higher level of ALP was not associated with cerebral atherosclerosis but was an independent prognostic factor for long-term functional outcome after acute cerebral infarction.

Keywords: alkaline phosphatase; atherosclerosis; phosphate; stroke.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alkaline Phosphatase / blood*
  • Brain Infarction / blood*
  • Female
  • Humans
  • Intracranial Arteriosclerosis / blood*
  • Male
  • Middle Aged
  • Phosphates / blood*
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Severity of Illness Index
  • Stroke / blood*

Substances

  • Phosphates
  • Alkaline Phosphatase